KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.

The Journal of Antibiotics
1992.0

Abstract

A novel compound, KS-505a was isolated from the culture broth of a strain identified as Streptomyces argenteolus A-2. The compound inhibited bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase with an IC50 value (the concentration causing 50% inhibition) of 0.065 microM. The compound around that concentration had little or no effect on heart calmodulin-dependent and -independent cyclic-nucleotide phosphodiesterases, and protein kinase C.

Knowledge Graph

Similar Paper

KS-505a, a novel inhibitor of bovine brain Ca2+ and calmodulin-dependent cyclic-nucleotide phosphodiesterase from Streptomyces argenteolus.
The Journal of Antibiotics 1992.0
Cloning of the Gene Cluster Responsible for Biosynthesis of KS-505a (Longestin), a Unique Tetraterpenoid
Bioscience, Biotechnology, and Biochemistry 2007.0
K-252a, a potent inhibitor of protein kinase C from microbial origin.
The Journal of Antibiotics 1986.0
Isolation and characterization of I5B2, a new phosphorus containing inhibitor of angiotensin I converting enzyme produced by Actinomadura sp.
The Journal of Antibiotics 1984.0
One new indolocarbazole alkaloid from the <i>Streptomyces</i> sp. A22
Natural Product Research 2018.0
MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.
The Journal of Antibiotics 1994.0
WS-9659 A and B, novel testosterone 5.ALPHA.-reductase inhibitors isolated from a Streptomyces. I. Taxonomy, fermentation, isolation, physico-chemical characteristics.
The Journal of Antibiotics 1989.0
MLR-52,(4'-dementhylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity.
The Journal of Antibiotics 1994.0
Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4.
The Journal of Antibiotics 1992.0
Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.
The Journal of Antibiotics 2018.0